Michael A. Mussallem, Director at Edwards Lifesciences Corp (EW), sold 58,700 shares at $85.08 ($5.0M) on 2023-06-01, disclosed to the SEC on 2023-06-01.
Scheduled sale ($5.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.43 | 5,300 | $442K | 8.9% |
| 2 | $83.43 | 5,300 | $442K | 8.9% |
| 3 | $84.57 | 18,654 | $1.6M | 31.8% |
| 4 | $84.57 | 18,654 | $1.6M | 31.8% |
| 5 | $85.08 | 5,396 | $459K | 9.3% |
| 6 | $85.08 | 5,396 |
| $459K |
| 9.3% |
| Total | $84.46 avg | 58,700 | $5.0M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |